The main findings from our initial work on these cell models are that cN-II is involved in cell migration, most probably through the regulation of Cox-2 expression and prostaglandin E2-production, and that CD73-deficient lung cancer cells had modified sensitivity to certain classical cancer drugs. The gene discussed is NT5C2; the disease is lung cancer.